Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT03123458
PHASE1
Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders
Sponsor: Shenzhen Geno-Immune Medical Institute
View on ClinicalTrials.gov
Summary
The primary objectives are to evaluate the safety and efficacy of infusion of the third party fully-characterized clonally derived fetal MSCs (cfMSCs) for the control of severe symptoms associated with acute and chronic immune-related disorders and tissue damage.
Key Details
Gender
All
Age Range
1 Year - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-01-01
Completion Date
2029-12-31
Last Updated
2026-06-22
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
clonal fetal MSCs
clonal fetal MSCs
Locations (1)
Shenzhen Geno-immune Medical Institute
Shenzhen, Guangdong, China